SevenOneSeven Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
SevenOneSeven Capital Management's RGEN Position: Q3 2022 in Review
SevenOneSeven Capital Management sold out of Repligen (RGEN) in Q3 2022, closing a stake of 1,595 shares — an estimated $259K sold.
SevenOneSeven Capital Management first reported a position in RGEN in Q2 2021 and held it in 5 quarters. The position peaked at $463K in Q3 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.
- SevenOneSeven Capital Management reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
- SevenOneSeven Capital Management sold 1,595 Repligen shares in Q3 2022, an estimated $259K.
- SevenOneSeven Capital Management first reported a position in Repligen in Q2 2021 and held it in 5 quarters.
- SevenOneSeven Capital Management's Repligen position peaked at $463K in Q3 2021.
- 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.
Based on SevenOneSeven Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.